Sumitomo Mitsui Ds Asset Management Company, LTD Moderna, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $9.6 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 34,863 shares of MRNA stock, worth $934,328. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,863
Previous 34,206
1.92%
Holding current value
$934,328
Previous $2.29 Million
36.59%
% of portfolio
0.02%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding MRNA
# of Institutions
926Shares Held
252MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.08 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.04 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$685 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$471 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$196 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...